Most importantly, the data indicate discordant risks for sarcopenia in males and females with IL-16 serum levels higher than 150 pg/mL (OR: 9.53, 95% CI: 1.09, 83.44, p = 0.029). This evidence concerns the gene IL16 and sarcopenia.